European Commission's John Dalli says no need for device pre-market approval
This article was originally published in SRA
John Dalli, the European commissioner in charge of the department responsible for medical device regulation, gave an impassioned speech last night at the European Parliament in which he argued against the need for a system of pre-market approval for medical devices and championed the industry’s need to innovate and patients’ needs to have access to innovative products.
You may also be interested in...
February sees some vitally important issues on the European Commission’s agenda, including areas where the medtech sector has been clamoring for progress in terms of clarity over the Commission's thinking and guidance documents. This year's meetings are plentiful and critical.
While the EU has selected the CND system as the basis for its nomenclature, GMDN is becoming increasingly valued on the US and international scene. How does it see its latest role panning out globally?
Updated medtech notified body figures from the European Commission always make headline news. But industry needs to see real appointments now, not a list of tricky-to-understand numbers.